Patents by Inventor James R. Kermode
James R. Kermode has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12186466Abstract: Disclosed herein are devices and methods related to UV disinfection of a transfer catheter during peritoneal dialysis. The transfer catheter comprises a first and second end, the second end comprising a transfer valve. The transfer valve body comprises an inlet, outlet, and a flush hole. The valve core comprises a notch configured to allow fluid flow between the various flow paths. The valve core and body are positioned off axis with respect to the fluid flow path. The transfer catheter can allow for a small volume kill zone, which can minimize the amount of UV required to disinfect the catheter.Type: GrantFiled: May 7, 2021Date of Patent: January 7, 2025Assignee: PuraCath Medical, Inc.Inventors: Douglas Murphy-Chutorian, James R. Kermode, Justin A. Lance, Julia A. Rasooly, Michael Rasooly, Charles Martin Schwimmer
-
Patent number: 11007361Abstract: Disclosed herein are devices and methods related to UV disinfection of a transfer catheter during peritoneal dialysis. The transfer catheter comprises a first and second end, the second end comprising a transfer valve. The transfer valve body comprises an inlet, outlet, and a flush hole. The valve core comprises a notch configured to allow fluid flow between the various flow paths. The valve core and body are positioned off axis with respect to the fluid flow path. The transfer catheter can allow for a small volume kill zone, which can minimize the amount of UV required to disinfect the catheter.Type: GrantFiled: June 4, 2015Date of Patent: May 18, 2021Assignee: PuraCath Medical, Inc.Inventors: Douglas Murphy-Chutorian, James R. Kermode, Justin A. Lance, Julia A. Rasooly, Michael Rasooly, Charles Martin Schwimmer
-
Patent number: 10064696Abstract: Systems for partitioning a ventricle of a heart include a partitioning device or implant, and an applicator for inserting, repositioning and/or removing the partitioning device. The implant may support the ventricle wall and may reduce the volume of the ventricle. The delivery system for delivering and deploying a partitioning device into a ventricle may include a catheter having a distal coupling element for coupling to a partitioning device in a collapsed configuration; the catheter may also have an expansion member for applying force to the partitioning device to fully expand it into a deployed configuration and to secure or seal it against the ventricle wall.Type: GrantFiled: April 19, 2016Date of Patent: September 4, 2018Inventors: Michael P. Boutillette, James R. Kermode, Miles D. Alexander, Alexander Khairkhahan, Serjan D. Nikolic
-
Patent number: 10028835Abstract: Devices and systems including implants (which may be removable) and methods of using them for reducing ventricular volume. The implants described herein are cardiac implants that may be inserted into a patient's heart, particularly the left ventricle. The implant may support the heart wall, or may be secured to the heart wall. The implants are typically ventricular partitioning device for partitioning the ventricle into productive and non-productive regions in order to reduce the ventricular volume.Type: GrantFiled: May 19, 2016Date of Patent: July 24, 2018Assignee: Edwards Lifesciences CorporationInventors: James R. Kermode, Miles D. Alexander, Michael P. Boutillette, Matthew T. Davila, Irene Bing Bie Tan
-
Patent number: 9364327Abstract: Devices and systems including implants (which may be removable) and methods of using them for reducing ventricular volume. The implants described herein are cardiac implants that may be inserted into a patient's heart, particularly the left ventricle. The implant may support the heart wall, or may be secured to the heart wall. The implants are typically ventricular partitioning device for partitioning the ventricle into productive and non-productive regions in order to reduce the ventricular volume.Type: GrantFiled: March 20, 2015Date of Patent: June 14, 2016Assignee: CardioKinetix, Inc.Inventors: James R. Kermode, Miles D. Alexander, Michael P. Boutillette, Matthew T. Davila, Irene Bing Bie Tan
-
Patent number: 9332993Abstract: Described herein are devices, systems and methods for delivering an endocardial device. The systems for delivering the device transvascularly may generally include an elongate guide catheter having a proximal end and a distal end; a conical dilator at the distal end of the elongate guide catheter, the conical dilator being removable to enable delivery of the ventricular portioning device; a delivery catheter having a proximal and distal end; an expansion member near the distal end of the delivery catheter and configured to expand a plurality of struts of the partitioning device; and a coupling element configured to deployably secure to a hub of the partitioning device. The systems for delivering the device transapically may generally include an elongate access sheath; an elongate delivery catheter; an expansion member; and a coupling element proximal to the expansion member and configured to deployably secure to a hub of the partitioning device.Type: GrantFiled: March 14, 2013Date of Patent: May 10, 2016Assignee: CardioKinetix, Inc.Inventors: James R. Kermode, Miles D. Alexander, Matthew T. Davila
-
Patent number: 9078660Abstract: Systems for partitioning a ventricle of a heart include a partitioning device or implant, and an applicator for inserting, repositioning and/or removing the partitioning device. The implant may support the ventricle wall and may reduce the volume of the ventricle. The delivery system for delivering and deploying a partitioning device into a ventricle may include a catheter having a distal coupling element for coupling to a partitioning device in a collapsed configuration; the catheter may also have an expansion member for applying force to the partitioning device to fully expand it into a deployed configuration and to secure or seal it against the ventricle wall.Type: GrantFiled: September 29, 2010Date of Patent: July 14, 2015Assignee: CardioKinetix, Inc.Inventors: Michael P. Boutillette, James R. Kermode, Miles D. Alexander, Alexander Khairkhahan, Serjan D. Nikolic
-
Patent number: 9039597Abstract: Devices and systems including implants (which may be removable) and methods of using them for reducing ventricular volume. The implants described herein are cardiac implants that may be inserted into a patient's heart, particularly the left ventricle. The implant may support the heart wall, or may be secured to the heart wall. The implants are typically ventricular partitioning device for partitioning the ventricle into productive and non-productive regions in order to reduce the ventricular volume.Type: GrantFiled: June 13, 2014Date of Patent: May 26, 2015Assignee: CardioKinetix, Inc.Inventors: James R. Kermode, Miles D. Alexander, Michael P. Boutillette, Matthew T. Davila, Irene Bing Bie Tan
-
Patent number: 8790242Abstract: Devices and systems including implants (which may be removable) and methods of using them for reducing ventricular volume. The implants described herein are cardiac implants that may be inserted into a patient's heart, particularly the left ventricle. The implant may support the heart wall, or may be secured to the heart wall. The implants are typically ventricular partitioning device for partitioning the ventricle into productive and non-productive regions in order to reduce the ventricular volume.Type: GrantFiled: October 26, 2010Date of Patent: July 29, 2014Assignee: CardioKinetix, Inc.Inventors: James R. Kermode, Miles D. Alexander, Michael P. Boutillette, Matthew T. Davila, Irene Bing Bie Tan
-
Patent number: 8377114Abstract: Described herein are partitioning devices for reducing ventricular volume that may be secured within a ventricle and separate it into a productive portion and a non-productive portion. The partitioning devices described herein may include a reinforced membrane and may be secured within the heart chamber by sealing them to the wall of the heart chamber, for example, by inflating an inflatable element on the periphery of the device. All or a region of the non-productive portion formed by these devices may be enclosed within a container or bag. The non-productive portion may be filled with a material, including occlusive materials (e.g., vasoclusive coils). Sealing and/or filling the non-productive portion formed by the devices described herein may help prevent leakage from the non-productive region. Also described herein are systems including these devices and methods of using them, which may be suitable for treating patients with heart disease, particularly congestive heart failure.Type: GrantFiled: April 10, 2009Date of Patent: February 19, 2013Assignee: Cardiokinetix, Inc.Inventors: Alexander Khairkhahan, Serjan D. Nikolic, James R. Kermode
-
Publication number: 20120238996Abstract: Methods and apparatus of embodiments of the invention are adapted to treat tissue inside a patient's body. Aspects of the invention can be used in a wide variety of applications, but certain embodiments provide minimally invasive alternatives for treating atrial fibrillation by delivering a tissue-damaging agent to selected areas of the heart. One exemplary embodiment of the invention provides a method of treating cardiac arrhythmia. This method includes positioning a distal tissue-contacting portion of a body in surface contact with a tissue surface of cardiac tissue; detecting the surface contact between the tissue-contacting portion and the tissue surface; and thereafter, injecting a tissue-ablating agent into the cardiac tissue through the tissue-contacting portion of the body.Type: ApplicationFiled: May 25, 2012Publication date: September 20, 2012Applicant: BOSTON SCIENTIFIC SCIMED, INC.Inventors: U. Hiram Chee, Richard L. Mueller, James R. Kermode, Curtis P. Tom, Douglas Murphy-Chutorian
-
Patent number: 8187251Abstract: Methods and apparatus of embodiments of the invention are adapted to treat tissue inside a patient's body. Aspects of the invention can be used in a wide variety of applications, but certain embodiments provide minimally invasive alternatives for treating atrial fibrillation by delivering a tissue-damaging agent to selected areas of the heart. One exemplary embodiment of the invention provides a method of treating cardiac arrhythmia. This method includes positioning a distal tissue-contacting portion of a body in surface contact with a tissue surface of cardiac tissue; detecting the surface contact between the tissue-contacting portion and the tissue surface; and thereafter, injecting a tissue-ablating agent into the cardiac tissue through the tissue-contacting portion of the body.Type: GrantFiled: October 31, 2006Date of Patent: May 29, 2012Assignee: Boston Scientific Scimed, Inc.Inventors: U. Hiram Chee, Richard L. Mueller, James R. Kermode, Curtis P. Tom, Douglas Murphy-Chutorian
-
Publication number: 20110098525Abstract: Devices and systems including implants (which may be removable) and methods of using them for reducing ventricular volume. The implants described herein are cardiac implants that may be inserted into a patient's heart, particularly the left ventricle. The implant may support the heart wall, or may be secured to the heart wall. The implants are typically ventricular partitioning device for partitioning the ventricle into productive and non-productive regions in order to reduce the ventricular volume.Type: ApplicationFiled: October 26, 2010Publication date: April 28, 2011Inventors: James R. Kermode, Miles D. Alexander, Michael P. Boutillette, Matthew T. Davila, Irene Bing Bie Tan
-
Publication number: 20110087066Abstract: Described herein are systems for partitioning a ventricle of a heart. The systems may include a partitioning device or implant, and an applicator for inserting, repositioning and/or removing the partitioning device. The implant may support the ventricle wall and may reduce the volume of the ventricle. In particular, described herein are systems for delivering and deploying a partitioning device into a ventricle. The delivery system may include a catheter having a distal coupling element for coupling to a partitioning device in a collapsed configuration; the catheter may also have an expansion member for applying force to the partitioning device to fully expand it into a deployed configuration and to secure or seal it against the ventricle wall.Type: ApplicationFiled: September 29, 2010Publication date: April 14, 2011Inventors: Michael P. Boutillette, James R. Kermode, Miles D. Alexander, Alexander Khairkhahan, Serjan D. Nikolic
-
Publication number: 20100262168Abstract: Described herein are partitioning devices for reducing ventricular volume that may be secured within a ventricle and separate it into a productive portion and a non-productive portion. The partitioning devices described herein may include a reinforced membrane and may be secured within the heart chamber by sealing them to the wall of the heart chamber, for example, by inflating an inflatable element on the periphery of the device. All or a region of the non-productive portion formed by these devices may be enclosed within a container or bag. The non-productive portion may be filled with a material, including occlusive materials (e.g., vasoclusive coils). Sealing and/or filling the non-productive portion formed by the devices described herein may help prevent leakage from the non-productive region. Also described herein are systems including these devices and methods of using them, which may be suitable for treating patients with heart disease, particularly congestive heart failure.Type: ApplicationFiled: April 10, 2009Publication date: October 14, 2010Inventors: Alexander Khairkhahan, Serjan D. Nikolic, James R. Kermode
-
Patent number: 7588554Abstract: The invention described herein provides for methods and devices for treating tissues, and in particular, ischemic heart tissue. Preferred devices includes tools integrating both injury and treatment effectors in a single unit. An optional third effector provides an effector for marking locations on a tissue surface that have been visited by the device. Methods are provided in which a target tissue is identified, injury sites are created at known locations, and therapeutic-substance is infused at known locations different than the injury sites.Type: GrantFiled: June 26, 2001Date of Patent: September 15, 2009Assignee: Boston Scientific Scimed, Inc.Inventors: Richard L. Mueller, U. Hiram Chee, James R. Kermode
-
Patent number: 7147633Abstract: Methods and apparatus of embodiments of the invention are adapted to treat tissue inside a patient's body. Aspects of the invention can be used in a wide variety of applications, but certain embodiments provide minimally invasive alternatives for treating atrial fibrillation by delivering a tissue-damaging agent to selected areas of the heart. One exemplary embodiment of the invention provides a method of treating cardiac arrhythmia. This method includes positioning a distal tissue-contacting portion of a body in surface contact with a tissue surface of cardiac tissue; detecting the surface contact between the tissue-contacting portion and the tissue surface; and thereafter, injecting a tissue-ablating agent into the cardiac tissue through the tissue-contacting portion of the body.Type: GrantFiled: March 14, 2002Date of Patent: December 12, 2006Assignee: Boston Scientific Scimed, Inc.Inventors: U. Hiram Chee, Richard L. Mueller, James R. Kermode, Curtis P. Tom, Douglas Murphy-Chutorian
-
Publication number: 20020183738Abstract: Methods and apparatus of embodiments of the invention are adapted to treat tissue inside a patient's body. Aspects of the invention can be used in a wide variety of applications, but certain embodiments provide minimally invasive alternatives for treating atrial fibrillation by delivering a tissue-damaging agent to selected areas of the heart. One exemplary embodiment of the invention provides a method of treating cardiac arrhythmia. This method includes positioning a distal tissue-contacting portion of a body in surface contact with a tissue surface of cardiac tissue; detecting the surface contact between the tissue-contacting portion and the tissue surface; and thereafter, injecting a tissue-ablating agent into the cardiac tissue through the tissue-contacting portion of the body.Type: ApplicationFiled: March 14, 2002Publication date: December 5, 2002Inventors: U. Hiram Chee, Richard L. Mueller, James R. Kermode, Curtis P. Tom, Douglas Murphy-Chutorian
-
Publication number: 20020072717Abstract: The invention described herein provides for methods and devices for treating tissues, and in particular, ischemic heart tissue. Preferred devices includes tools integrating both injury and treatment effectors in a single unit. An optional third effector provides an effector for marking locations on a tissue surface that have been visited by the device. Methods are provided in which a target tissue is identified, injury sites are created at known locations, and therapeutic-substance is infused at known locations different than the injury sites.Type: ApplicationFiled: June 26, 2001Publication date: June 13, 2002Inventors: Richard L. Mueller, U. Hiram Chee, James R. Kermode
-
Patent number: 5935137Abstract: An apparatus and method for human female sterilization. The apparatus includes an occlusive device configured from an elongate tubular member having a central lumen and a flange formed at the proximal end. The occlusive device is formed with a plurality of flexible ribs configured to provide a plurality of seals within the interstitial portion of a Fallopian tube. A valve member is preferably disposed within the lumen of the tubular member. The occlusive device may further include a plurality of copper rings disposed between the ribs of the tubular member, or ribs may be coated with a material containing copper. The method includes placing the occlusive device within a delivery catheter having a lumen and placing the distal end of the delivery catheter within the uterus. After the occlusive device and distal end of the delivery catheter are placed in the Fallopian tube, the occlusive device is removed from the delivery catheter and ejected into the Fallopian tube.Type: GrantFiled: July 18, 1997Date of Patent: August 10, 1999Assignee: Gynecare, Inc.Inventors: Vahid Saadat, James R. Kermode